QHSLab, Inc. (USAQ)

QHSLab, Inc. is a healthcare software and digital medicine company focused on equipping primary care physicians with tools to screen for, diagnose, and manage chronic disease and preventive health conditions. The company, formerly known as USA Equities Corp., rebranded to QHSLab in 2022 and has since built a growing suite of cloud-based assessment and practice-management products serving medical offices directly.

The company’s origin is worth noting. It was incorporated in 1983 and traded in various forms before being recapitalized and refocused on healthcare software. The shift to QHSLab brand and strategy represents a deliberate reset toward a specific market: the primary care physician’s office, where most routine patient screening, initial diagnosis, and ongoing chronic disease management happens. QHSLab’s pitch is straightforward—give primary care doctors better tools to identify conditions early, manage them efficiently, and keep patients out of expensive specialist referral or hospitalization.

The problem QHSLab is solving

Primary care is the foundation of any healthcare system, but primary care doctors are time-starved and under-resourced. They see dozens of patients per day, each with competing needs, and many patients present with conditions that are underdiagnosed or misdiagnosed because systematic screening is not in place. A patient walks in with fatigue; the doctor may miss the underlying sleep apnea, allergic rhinitis, or thyroid disorder because the visit is 15 minutes and the symptom list is long. A teenager with anxiety might be sent home without assessment or might sit untreated because the doctor lacks a reliable screening framework.

QHSLab’s products are designed to fill that gap. They provide structured digital assessments that patients complete before or during their visit, feeding the doctor actionable data about symptoms, risk factors, and potential conditions. The platform also includes practice-management tools—scheduling, patient education, workflow optimization—that help the medical office run more efficiently and keep better track of patient outcomes.

Building a software business one practice at a time

QHSLab’s revenue model rests on getting medical practices to adopt its platform and use it repeatedly. The company does not generate revenue from patients directly; it charges the medical offices that license the software. Doctors and practices subscribe, pay implementation fees for onboarding, and then generate recurring monthly or annual licensing fees as they use the platform with patients.

The unit economics of a healthcare software business depend on customer acquisition cost, customer lifetime value, and churn. A primary care practice is typically a small business—a few doctors, maybe a nurse practitioner or two, support staff. The practice must see enough value in the QHSLab platform to justify the cost and the effort of integrating it into its workflow. That value comes from two places: better clinical outcomes (catching conditions early, managing them more systematically) and operational efficiency (faster visits, better documentation, higher reimbursement if the assessments qualify as billable services).

Revenue growth, then, requires two things: adding new medical practices as customers and increasing the recurring assessment volume within each existing practice. As of the first nine months of 2025, the company reported revenue of approximately $1.99 million, up 32% year-over-year. Gross margins stood at 66%, which is healthy for a software business and reflects the high-margin nature of digital products once the infrastructure is built.

What QHSLab actually offers

The company provides a suite of digital assessments and tools organized around specific areas of patient health. Mental health assessments help primary care doctors screen for depression, anxiety, and other psychological conditions. Respiratory and allergy diagnostics allow structured diagnosis and assessment of asthma, rhinitis, and related conditions. Chronic pain management tools help doctors and patients track and manage back pain, arthritis, and similar conditions. Lifestyle and preventive care solutions address weight, sleep, exercise, and other modifiable risk factors.

Each assessment is a questionnaire or structured data-collection tool that a patient completes—either on a tablet in the office waiting room or via a mobile app at home before the visit. The platform aggregates responses, flags risk factors, and presents the doctor with a summary that can guide the visit. The patient also receives feedback, education, and recommendations for management.

This is fundamentally a software-as-a-service (SaaS) business. The company builds and maintains the platform, hosting it in the cloud, updating it with new assessments or features, and ensuring it integrates with the practice’s electronic health record system. The practice receives a login and can deploy assessments, track patient progress, and generate reports.

From legacy to healthcare focus: The origin story

QHSLab has undergone a complete business transformation. It was not always a healthcare software company. The company was incorporated decades ago, traded in various sectors, and was largely dormant or in other businesses until it was recapitalized and refocused on digital health. That transformation is important context: it shows the company recognized an opportunity, raised capital, and pivoted entirely to pursue it. The previous identity is largely irrelevant; the business today is determined by the healthcare strategy.

The company has been building this healthcare software focus over several years, with particular emphasis since the 2022 rebranding. The emphasis on primary care—not specialists, not hospitals, not consumers buying health apps—is deliberate. The primary care market is underserved by software vendors, less competitive than consumer-facing health apps, and represents a significant and recurring revenue opportunity if the product gains traction.

Key metrics and growth drivers

The company’s growth trajectory rests on three pillars. First is the number of active medical practices using the platform—that is the installed base and the source of recurring revenue. Second is the assessment volume per practice—how many patients each practice runs through the QHSLab assessments each month. Third is the rate of adoption by new practices and the rate of churn (practices that stop using the platform).

With revenue growing 32% year-over-year and gross margins at 66%, the company is demonstrating product-market fit among its current customer base. The challenge is whether it can maintain that growth rate as it expands beyond early adopters. Primary care practices, especially small independent ones, are conservative buyers. They need proof that the platform integrates smoothly with their workflow, that patients actually use it, and that it improves either their bottom line or their clinical outcomes. QHSLab is still in the phase of proving that proof across a broader base.

Pressures and competitive terrain

QHSLab competes in the crowded digital health and healthcare IT space, but its niche is relatively specific: primary care assessment and practice management. It faces competition from larger established healthcare IT vendors, specialized companies building for particular conditions or patient populations, and consumer health apps.

The regulatory environment around healthcare software is important. QHSLab’s assessments must be medically valid; its billing claims must be compliant; its data handling must meet HIPAA and other privacy standards. A misstep in compliance could damage the business materially.

Second is the dependency on healthcare reimbursement. If assessment-based management by primary care physicians becomes reimbursable by insurance, that is a major growth accelerant—practices would deploy the tool more aggressively if it helps them earn higher reimbursement per patient. If reimbursement remains uncertain or minimal, adoption will be slower.

Third is integration risk. QHSLab’s platform must integrate with electronic health records systems used by medical practices. If integration is clunky, adoption suffers. This is an ongoing technical and business challenge, not a one-time problem.

How to research QHSLab as an investment

Start with the quarterly and annual filings (SEC CIK 0000856984). Track revenue growth and gross margin to see whether the company can maintain its current trajectory. Watch for customer acquisition metrics if the company discloses them—the number of practices added and the churn rate are critical.

Listen to earnings calls or investor updates for commentary on customer adoption, reimbursement developments, and competitive positioning. Any significant slowdown in growth, loss of large practices, or change in healthcare reimbursement policy would affect the investment case. Similarly, expansion into new assessment areas or major customer wins would signal momentum. The company is still in the growth phase, proving that primary care practices will systematically adopt digital assessment tools and that QHSLab is the vehicle they choose.